Conceptual Modelling for Cost-Effectiveness Analysis of Intravitreal Therapy with Ranibizumab, Aflibercept or Bevacizumab for Macular Oedema Due to Central Retinal Vein Occlusion
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.116
https://www.valueinhealthjournal.com/article/S1098-3015(16)31483-8/fulltext
Title :
Conceptual Modelling for Cost-Effectiveness Analysis of Intravitreal Therapy with Ranibizumab, Aflibercept or Bevacizumab for Macular Oedema Due to Central Retinal Vein Occlusion
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)31483-8&doi=10.1016/j.jval.2016.09.116
First page :
A366
Section Title :
Research on Methods Studies
Open access? :
No
Section Order :
104